LAURA NOBLE: Open Payments
NPI 1164875191 · CLINTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$145 in 7 payments from 7 companies in 2025. Trend: 2023 $42 · 2024 $258 · 2025 $145
Food & beverage: $145
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Eisai Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| AtriCure, Inc. | 1 | $21 |
| Stemline Therapeutics Inc. | 1 | $17 |
| TAIHO ONCOLOGY, INC. | 1 | $15 |
Products named: KEYTRUDA, JEMPERLI, Lenvima, ATRICLIP LAA EXCLUSION SYSTEM, Orserdu, LONSURF.
Industry payments across MO — which companies pay providers there.
